At Fred Hutch Cancer Center, our team of experts cares for people with multiple myeloma every day. Here, you will receive comprehensive multiple myeloma treatment from providers who are dedicated to ...
Elotuzumab, an immunostimulatory monoclonal antibody targeting signaling lymphocytic activation molecule F7 (SLAMF7), showed activity in combination with lenalidomide and dexamethasone in a phase 1b–2 ...
Genetic abnormalities alter the expression of adhesion molecules on myeloma cells, as well as responses to growth stimuli in the microenvironment (Figure 2). Interactions between myeloma cells and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results